•  
  •  
 

Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science

Specialty

Internal Medicine

Advisor

Dr. Nancy Reid

Abstract

Subclinical hypothyroidism (SCH) is a condition commonly diagnosed and treated in the primary care community. However, data is still lacking to support which groups of patients assume a benefit from treatment of SCH. The article below will briefly review the diagnosis of SCH, determining appropriate patients for treatment and primary benefits of treatment. In addition, populations will be identified as to whom may be effected negatively by starting or continuing treatment for SCH. Further, we will explore specific populations that fall into the “grey zone” of SCH, which we have defined as a TSH level of 7.0mU/L to 9.9mU/L. Suggestions will be presented as to how practitioners might decide which patients to treat in this “grey zone” and which to exclude, with an emphasis on consideration of individual cardiac risk.

Restricted

Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.

Share

COinS